We describe a case of apparent trisomy 21 that does not fulfil the criteria for the clinical diagnosis of Down's syndrome (DS). Our patient was subjected to karyotype analysis and found to have full, non-mosaic trisomy 21 in both blood lymphocytes and skin fibroblasts, while examination of the term placenta, which was performed earlier in the course of a different study, had shown mosaicism (73%) for trisomy 21. FISH analysis showed no obvious rearrangement of the DS chromosomal region in any of the chromosomes 21. Molecular analysis using polymorphic markers on chromosome 21 verified the existence of trisomy for the entire long arm ofthe chromosome and showed that the origin of the extra chromosome was maternal and was probably the result of a mitotic error. In contrast with the above, the clinical evaluation using the Jackson checklist of 25 signs failed to establish the diagnosis of DS. We believe that our patient might present mosaicism in other tissues that are not available for analysis and can be regarded as an extreme example in the continuous spectrum of karyotypei phenotype associations in mosaic cases.
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Materials and methods

CASE REPORT
The patient was examined twice independently. The first examination was during a study on the possible association of growth retardation in otherwise normal children with confined placental mosaicism." The patient had mosaic trisomy 21 in the placenta but was finally not included in that study because of the slightly abnormal phenotypic features that she presented. The patient was referred to us at the age of 1 week because of her phenotypic features. At 2 months, 4 years, and 4.7 years of age, careful evaluation of the phenotype, karyotype analysis in blood lymphocytes and fibroblasts, and molecular analysis on DNA from blood were performed. The mental status of the patient has unfortunately been influenced by Haemophilus influenzae meningitis that occurred at the age of 12 months.
CYTOGENETIC ANALYSIS
Chromosome analyses were performed after standard preparation of fibroblast cultures and PHA stimulated lymphocyte cultures with subsequent GTG and QFQ banding, respectively. Long term placental cultures and chromosome preparations were established as described elsewhere.'2 FISH ANALYSIS Metaphase chromosomes were obtained from skin fibroblasts from the patient. Cosmid probes (1 gg of each) were labelled by nick group.bmj.com on June 20, 2017 -Published by http://jmg.bmj.com/ Downloaded from translation using biotin-14-dATP (BRL), purified by passage through G50 Sephadex, and precipitated with 3 mol/l sodium acetate in the presence of salmon sperm DNA and ethanol. Probes were dissolved in 40 tl hybridisation buffer with 100 fold human DNA as competitor and denatured at 100°C for 10 minutes. In situ hybridisation was performed according to a previously described protocol,"3 and antibiotin FITC conjugated antibody was used for detection. Chromosome preparations were counterstained with propidium iodide and examined with a Zeiss Axiophot microscope.
Cosmid c103E0669 was isolated by screening a chromosome 21 specific cosmid library with the probe D21S395." Cosmids LLNL35A7 and LLNL51G9 have been described and localised in other reports'9 (Delabar et al, unpublished data).
MOLECULAR ANALYSIS
Genomic DNA from blood lymphocytes of the proband and her parents was extracted using standard procedures.'6 The DNA was used for polymerase chain reaction (PCR) amplification of polymorphic short sequence repeat sequences (microsatellites). The polymorphic alleles were visualised after end labelling of primer, electrophoresis of the radiolabelled PCR products through denaturing acrylamide gels, and autoradiography, as previously described.'7 18 The scoring of polymorphic alleles was performed as previously described'9 using numbers beginning with the shorter and increasing towards the longer alleles. After analysis of 20 polymorphic DNA markers along the long arm of chromosome 21, 14 markers were informative for the trisomy based on dosage analysis (table 3) . On the basis of 11 informative markers, a maternal origin of the extra chromosome could be recognised (table 3) . Since 16 markers along the entire length of the long arm of chromosome 21 represented "reduction to homozygosity" of maternal alleles, and as a third allele was not detected in the patient, the extra chromosome most likely originated by mitotic rather than by meiotic non-disjunction.24 Discussion We report here a case of apparent trisomy 21 without the DS phenotype. We base the clinical exclusion of DS on the failure to fulfil the minimum five criteria of the Jackson sign checklist which has proven to be a very reliable tool for the diagnosis of DS. Our patient clearly presented only two of the signs on the list, while more than 13 are required for an unambiguous However, this explanation is not likely in our case since FISH analysis with three cosmid probes mapping to the DCR showed hybridisation to the three chromosomes 21. A small deletion of part of the DCR, not covered by the cosmids used, cannot be completely excluded, as this would need more than 50 hybridisations. The possible existence of genetic or other factors that could have a protective effect cannot be ruled out, but also seems unlikely since the phenomenon has not been observed before. Unfortunately, other tissues were not available for study and therefore we cannot support or rule out the possibility of mosaicism in other tissues critical for the expression of the DS phenotype.
In conclusion, our patient could be regarded as an extreme example which can be expected in a continuous spectrum of karyotype/ phenotype associations in mosaic cases. Furthermore, the case underlines the need for karyotype analysis in children with mental retardation of unknown aetiology.
